Neglected Testing for Neglected Tropical Diseases at the CDC

View More View Less
  • 1 Division of Infectious Diseases and Global Medicine, University of Florida College of Medicine, Gainesville, Florida;
  • | 2 Drugs for Neglected Diseases Initiative, New York, New York;
  • | 3 Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;
  • | 4 Department of Global Health, Boston University School of Public Health, Boston, Massachusetts;
  • | 5 Boston Medical Center, Boston, Massachusetts;
  • | 6 Boston University School of Medicine, Boston, Massachusetts;
  • | 7 Division of Infectious Diseases, University of Colorado, Anschutz Medical Campus, Aurora, Colorado;
  • | 8 Division of Infectious Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts;
  • | 9 Latin American Society of Chagas, Bristow, Virginia;
  • | 10 Medstar Union Memorial and Good Samaritan Hospitals, Baltimore, Maryland;
  • | 11 David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California;
  • | 12 Olive View-UCLA Medical Center, Los Angeles, California;
  • | 13 Harvard T.H. Chan School of Public Health, Boston, Massachusetts;
  • | 14 Division of Infectious Disease, Georgetown University Hospital, Washington, District of Columbia;
  • | 15 Division of Global Health and Environmental Health, School of Public Health, San Diego State University, San Diego, California

Author Notes

Address correspondence to Michael R. Reich, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA 02115. E-mail: michael_reich@harvard.edu

Authors’ addresses: Norman L. Beatty, Division of Infectious Diseases and Global Medicine, University of Florida College of Medicine, Gainesville, FL, E-mail: norman.beatty@medicine.ufl.edu. Colin J. Forsyth, Drugs for Neglected Diseases Initiative, New York, NY, E-mail: cforsyth@dndi.org. Robert H. Gilman, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, E-mail: gilmanbob@gmail.com. Davidson H. Hamer, Boston University Schools of Public Health and Medicine, Boston, MA, E-mail: dhamer@bu.edu. Andrés F. Henao-Martínez, Division of Infectious Diseases, University of Colorado, Anschutz Medical Campus, Aurora, CO, E-mail: andres.henaomartinez@cuanschutz.edu. Natasha Hochberg, Boston Medical Center, Boston, MA, and Boston University School of Medicine, Boston, MA, E-mail: nhoch@bu.edu. Jen Manne-Goehler, Division of Infectious Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, E-mail: jen.manne@gmail.com. Rachel Marcus, Latin American Society of Chagas, Bristow, VA, and Medstar Union Memorial and Good Samaritan Hospitals, Baltimore, MD, E-mail: doctorchagas@gmail.com. Sheba Meymandi, Michael R. Reich, Harvard T.H. Chan School of Public Health, Boston, MA, E-mail: michael_reich@harvard.edu. David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, CA, and Olive View-UCLA Medical Center, Los Angeles, CA, E-mail: smeymandi@dhs.lacounty.gov. Adrienne Showler, Division of Infectious Disease, Georgetown University Hospital, Washington, DC, E-mail: showler@gunet.georgetown.edu. Paula Stigler Granados, Division of Global Health and Environmental Health, School of Public Health, San Diego State University, San Diego, CA, E-mail: paula.stigler@gmail.com.

Save